Drug treatment of bipolar depression and mania.
Bipolar manic-depressive disorder may present as mania, depression, or mixed states, and there is increasing knowledge of its responsiveness to drugs as therapeutic agents. In addition a number of drugs may act as aggravating factors for the disorder.
Cookson
J C
JC
D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics / Q000517:prevention & control; D001971:Bromocriptine / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D008996:Monoamine Oxidase Inhibitors; D010713:Phosphatidylcholines; D002220:Carbamazepine; D001971:Bromocriptine; D014635:Valproic Acid; D014364:Tryptophan; D008094:Lithium; D014700:Verapamil; D003000:Clonidine